A Simple Paper-Based, Wearable Device for Long Term Sweat Analysis
|
By LabMedica International staff writers Posted on 16 Jun 2020 |

Image: The evaporation of sweat on paper pads could be used for fluid transport in a wearable device over long periods of time. The resulting dry layer of caked salts would preserve a `time-stamped` record of biomarkers of interest (Photo courtesy of Dr. Orlin D. Velev and co-authors, North Carolina State University)
By cleverly manipulating paper geometry, researchers created a paper-based wearable device to collect, transport, and analyze sweat for an extended period.
Sweat can be used to obtain an exact measurement of concentrations of medications in the blood. Furthermore, the concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids such as sweat predict the physical and mental state of the individual.
A major problem that has so far restricted the use of wearable paper-based sweat sensors is that sweat contains salt, which, upon evaporation, becomes deposited on the device and interferes with fluid flow. To solve this problem, investigators at North Carolina State University (Raleigh, USA) characterized and analyzed how capillary action and evaporation could cooperatively be used to transport and process a sweat-like fluid containing dissolved salts and model analytes.
The investigators postulated that the joint action of capillary wicking and evaporation would sustain continuous and long-term withdrawal of the sweat-like fluid. In the laboratory they then demonstrated that paper strips of controlled geometry could passively pump fluid for sensing purposes for long duration. Thus, non-invasive osmotic extraction combined with paper microfluidics and evaporative disposal enabled sweat collection and monitoring for periods exceeding 10 days. Since the process was driven by the liquid wicking through paper, the device did not require an external power source.
The investigators also demonstrated that the salt film deposited at the evaporation pad would eventually lead to cessation of the process but at the same time would preserve a record of analytes that could be used for long-term biomarker monitoring in sweat.
"We expected that the flow of the model sweat will be suppressed by the deposition of a salt layer inside the drying pad," said senior author Dr. Orlin Velev, professor of chemical and biomolecular engineering at North Carolina State University. "By following the flow of model sweat, we found, quite surprisingly, that such a simple paper construct can achieve continuous sweat pumping and disposal for very long periods."
The wearable device for sweat analysis was described in the June 9, 2020, online edition of the journal Biomicrofluidics.
Related Links:
North Carolina State University
Sweat can be used to obtain an exact measurement of concentrations of medications in the blood. Furthermore, the concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids such as sweat predict the physical and mental state of the individual.
A major problem that has so far restricted the use of wearable paper-based sweat sensors is that sweat contains salt, which, upon evaporation, becomes deposited on the device and interferes with fluid flow. To solve this problem, investigators at North Carolina State University (Raleigh, USA) characterized and analyzed how capillary action and evaporation could cooperatively be used to transport and process a sweat-like fluid containing dissolved salts and model analytes.
The investigators postulated that the joint action of capillary wicking and evaporation would sustain continuous and long-term withdrawal of the sweat-like fluid. In the laboratory they then demonstrated that paper strips of controlled geometry could passively pump fluid for sensing purposes for long duration. Thus, non-invasive osmotic extraction combined with paper microfluidics and evaporative disposal enabled sweat collection and monitoring for periods exceeding 10 days. Since the process was driven by the liquid wicking through paper, the device did not require an external power source.
The investigators also demonstrated that the salt film deposited at the evaporation pad would eventually lead to cessation of the process but at the same time would preserve a record of analytes that could be used for long-term biomarker monitoring in sweat.
"We expected that the flow of the model sweat will be suppressed by the deposition of a salt layer inside the drying pad," said senior author Dr. Orlin Velev, professor of chemical and biomolecular engineering at North Carolina State University. "By following the flow of model sweat, we found, quite surprisingly, that such a simple paper construct can achieve continuous sweat pumping and disposal for very long periods."
The wearable device for sweat analysis was described in the June 9, 2020, online edition of the journal Biomicrofluidics.
Related Links:
North Carolina State University
Latest Molecular Diagnostics News
- Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response
- Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring
- Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing
- Whole-Blood RNA Test Predicts Disease Trajectory and Treatment Response
- Blood-Based Epigenetic Test Predicts GLP-1 Response and Tracks Treatment Effects
- Tumor Genomic Testing Guides Immunotherapy Selection in Pituitary Tumors
- Liquid Biopsy Predicts Immunotherapy Response in Breast Cancer
- New Blood Test Distinguishes Pancreatic Cancer From Benign Disease
- Noninvasive Test Confirms High-Risk Prenatal Screening Results from Blood
- Machine-Learning Genetic Risk Score Improves Early Prediction of Type 1 Diabetes
- Rapid Tongue Swab Molecular Test Detects Pulmonary Tuberculosis at Point of Care
- CRISPR-Based Test Identifies Multiple Respiratory Viruses Simultaneously
- Blood Test Receives FDA Breakthrough Status to Differentiate Schizophrenia and Bipolar Disorder
- Portable Test Detects Tuberculosis from Tongue Swabs in 30 Minutes
- Multi-Omic Assay Predicts Recurrence and Radiation Benefit in Early Breast Cancer
- Genomic Risk Score Identifies Inherited Risk for Multiple Cardiovascular Conditions
Channels
Clinical Chemistry
view channel
Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
Dementia affects more than 57 million people worldwide and is projected to nearly double within two decades, straining health systems and families. While biomarkers now enable accurate identification of... Read more
Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
High blood pressure during pregnancy is common and can progress to pre-eclampsia, making close monitoring at antenatal visits essential. However, most risk assessment begins only after pregnancy has started.... Read moreHematology
view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read more
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Bone marrow biopsies remain central to diagnosing and monitoring multiple myeloma, yet the procedure is painful, invasive, and often repeated over time. Older patients—who represent most new cases—can... Read moreImmunology
view channel
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
Mpox outbreaks in non-endemic regions have underscored the need for rapid, accessible diagnostics to limit transmission. Polymerase chain reaction (PCR) remains the clinical reference, yet it depends on... Read more
T-Cell Senescence Profiling May Predict CAR T Responses
Chimeric antigen receptor (CAR) T-cell therapy can deliver striking, durable remissions, yet many patients experience minimal or no benefit. The quality of patient-derived cytotoxic T lymphocytes used... Read moreMicrobiology
view channel
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreTechnology
view channel
Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
Pancreatic cancer remains one of the hardest malignancies to treat because tumors are embedded within a dense microenvironment that shapes growth and therapy response. Standard laboratory models often... Read more
New Platform Captures Extracellular Vesicles for Early Cancer Detection
Early diagnosis remains the most effective way to reduce cancer mortality, yet many screening tools miss disease at its earliest stages. Biomarkers shed by tumors into blood and other fluids can be scarce... Read moreIndustry
view channel
Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
Roche has entered into a definitive merger agreement to acquire PathAI, a company focused on digital pathology and artificial intelligence for pathology laboratories and the biopharma industry.... Read more








